Human immunodeficiency virus infections

Karlsson GB, Halloran M, Schenten D, Lee J, Racz P, Tenner-Racz K, Manola J, Gelman R, Etemad-Moghadam B, Desjardins E, Wyatt R, Gerard NP, Marcon L, Margolin D, Fanton J, Axthelm MK, Letvin NL, Sodroski J (1998) The envelope glycoprotein ectodomains determine the efficiency of CD4+ T lymphocyte depletion in simian- human immunodeficiency virus-infected macaques. J Exp Med 188 1159-1171... [Pg.196]

Richardson JH, Child LA, Lever AM (1993) Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5 leader region, J Virol 67 3997 005 Roberts MR, Qin L, Zhang D, Smith DH, Tran AC, Dull TJ, Groopman JE, Capon DJ, Bym RA, Finer MH (1994) Targeting of human immunodeficiency virus-infected cells by CD8-I- T lymphocytes armed with universal T-cell receptors. Blood 84 2878-2889 Rooney CM, Smith CA, Ng CY, Loftin S, Li C, Krance RA, Brenner MK, Heslop HE (1995) Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lympho-proliferation. Lancet 345 9-13... [Pg.295]

Walker CM, Levy JA (1989) A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication. Immunology 66 628-630 Walker RE, Bechtel CM, Natarajan V, Baseler M, Hege KM, Metcalf JA, Stevens R, Hazen A, Blaese RM, Chen CC, Lehman SF, Palensky J, Wittes J, Davey RT, Falloon J, Polls MA, Ko-vacs JA, Broad DF, Levine BL, Roberts MR, Masur H, Lane HC (2000) Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection. Blood 96 467 74... [Pg.298]

Wiley CA, MasUah E, Morey M, Lemere C, DeTeresa R, Grafe M, Hansen L, Terry R (1991) Neocorfical damage during HIV infection. Ann Neurol 29(6) 651-657 Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83(18) 7089-7093 Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, Kim WK, Fuller RA, Kim JP, Autissier... [Pg.31]

Lores P, Boucher V, Mackay C, Pla M, Von Boehmer H, Jami J, Barre-Sinoussi E, Weill JC (1992) Expression of human CD4 in transgenic mice does not confer sensitivity to human immunodeficiency virus infection. AIDS Res Hum Retroviruses 8 2063-2071 Maddon PJ, Dalgleish AG, McDougal JS, Clapham PR, Weiss RA, Axel R (1986) The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47 333-348... [Pg.47]

Barohn RJ, Gronseth GS et al (1993) Peripheral nervous system involvement in a large cohort of human immunodeficiency virus-infected individuals. Arch Neurol 50(2) 167-171 Behar R, Wiley C et al (1987) Cytomegalovirus polyradiculoneuropathy in acquired immune deficiency syndrome. Neurology 37(4) 557-561... [Pg.77]

Blum AS, Dal Pan GJ et al (1996) Low-dose zalcitabine-related toxic neuropathy frequency, natural history, and risk factors. Neurology 46(4) 999-1003 Bradley WG, Verma A (1996) Painful vascuhtic neuropathy in HlV-1 infection relief of pain with prednisone therapy. Neurology 47(6) 1446-1451 Breen EC (2002) Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther 95(3) 295-304 Bremer J (1990) The role of carnitine in intracellular metabolism. J Clin Chem Clin Biochem 28(5) 297-301... [Pg.78]

Cornblath DR (1988) Treatment of the neuromuscular complications of human immunodeficiency virus infection. Ann Neurol 23(Suppl) S88-S91... [Pg.79]

Fleishman JA, Hellinger FH (2003) Recent trends in HIV-related inpatient admissions 1996-2000 a 7-state study. J Acquir Immune Defic Syndr 34(1) 102-110 Freeman R, Roberts MS et al (1990) Autonomic function and human immunodeficiency virus infection. Neurology 40(4) 575-580... [Pg.79]

Hoffman PM, Festoff BW et al (1985) Isolation of LAV/HTLV-III from a patient with amyotrophic lateral sclerosis. N Engl J Med 313(5) 324-325 Hoke A, Cornblath DR (2004) Peripheral neuropathies in human immunodeficiency virus infection. Suppl Clin Neurophysiol 57 195-210... [Pg.80]

Paice JA, Ferrans CE et al (2000) Topical capsaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manage 19(l) 45-52 Palella FJ Jr, Delaney KM et al (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338(13) 853-860... [Pg.82]

Puthanakit T, Oberdorfer P et al (2006) Immune reconstitution syndrome after highly active antiretroviral therapy in human immunodeficiency virus-infected thai children. Pediatr Infect Dis J... [Pg.83]

Simpson DM, Tagliati M (1995) Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol 9(2) 153-161... [Pg.84]

Welby SB, Rogerson SJ et al (1991) Autonomic neuropathy is common in human immunodeficiency virus infection. J Infect 23(2) 123-128... [Pg.86]

Adams M, Sharmeen L, Kimpton J, Romeo JM, Garcia JV, Peterlin BM, Groudine M, Emerman M (1994) Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci USA 91(9) 3862-3866... [Pg.108]

Harbol AW, Liesveld JL, Simpson-Haidaiis PJ, Abboud CN (1994) Mechanisms of cytopenia in human immunodeficiency virus infection. Blood Rev 8(4) 241-251 Harris RS, Sheehy AM, Craig HM, Malim MH, Neuberger MS (2003) DNA deamination not just a trigger for antibody diversification but also a mechanism for defense against retroviruses. Nat Immunol 4(7) 641-643... [Pg.112]

Thieblemont N, Weiss L, Sadeghi HM, Estcourt C, Haeffner-Cavaillon N(1995)CD141owCD 16high a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur J Immunol 25(12) 3418-3424... [Pg.116]

Perea S, JL Lopez-Ribot, WR Kirkpatrick, RK McAtee, RA Santillan, M Martinez, D Calabrese, D Sanglard, TP Patterson (2001) Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antibicrob Agents Chemother 45 2676-2684. [Pg.179]

For nearly 80% of patients with epilepsy, the underlying etiology is unknown.8 The most common recognized causes of epilepsy are head trauma and stroke. Developmental and genetic defects are the cause of about 5% of cases of epilepsy. Central nervous system (CNS) tumors, central nervous system infections, and neurodegen-erative diseases are other common causes. Other important causes of epilepsy are human immunodeficiency virus infection or neuro-cysticercosis infection, primarily occurring in Latin America. [Pg.444]

FIGURE 84-1. Life cycle of HIV and targets for antiretroviral drugs. (From Fletcher CV, Kakuda TN. Human immunodeficiency virus infection. In DiPiro JT, Talbert RL, Yee GC, et al, (eds.) Pharmacotherapy A Pathophysiologic Approach. 6th ed. New York McGraw-Hill 2005 2258, with permission.)... [Pg.1255]

See also in sourсe #XX -- [ Pg.200 , Pg.201 , Pg.202 , Pg.203 , Pg.204 , Pg.205 , Pg.206 , Pg.207 , Pg.208 , Pg.209 , Pg.210 , Pg.211 , Pg.212 , Pg.213 , Pg.214 , Pg.215 , Pg.216 , Pg.217 ]

See also in sourсe #XX -- [ Pg.129 ]

See also in sourсe #XX -- [ Pg.201 ]

See also in sourсe #XX -- [ Pg.550 , Pg.552 ]

See also in sourсe #XX -- [ Pg.272 , Pg.273 ]

See also in sourсe #XX -- [ Pg.342 ]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...